Subscribe

IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJ-D-16-00263

Coronary magnetic resonance angiographic images of a lesion treated with a metal stent and fully bioresorbable polymeric everolimus-eluting scaffold

Jiro Aoki1*, MD, PhD; Satoru Kishi2, MD; Shigeru Saito3, MD, PhD; Kengo Tanabe1, MD, PhD

A 48-year-old man was referred to our hospital for acute coronary syndrome. Coronary metal stents were implanted at the distal right coronary artery as the culprit lesion (pre-treatment: Panel A; post-treatment: Panel B). After one month, he was readmitted to our hospital in order to treat the remaining coronary artery stenosis. He was enrolled in the ABSORB EXTEND study, and a fully bioresorbable polymeric everolimus-eluting scaffold (Absorb; Abbott Vascular, Santa Clara, CA, USA) was implanted at the mid left circumflex coronary artery (pre-treatment: Panel C; post-treatment: Panel D). Follow-up coronary computed tomographic angiography was performed at eight months after the scaffold implantation. Mild stenosis and small platinum markers at scaffold edges were depicted at the mid left circumflex coronary artery (Panel E). At three years following the scaffold implantation, coronary magnetic resonance angiography (MRA) was performed to check his coronary artery. A coronary luminal image was not obtained at the metal stent site due to metal artefact (Panel F). However, a coronary luminal image was clearly obtained at the scaffold site (Panel G). No restenosis was observed, and the small platinum markers did not hamper lumen visibility. The patient is currently doing well without symptoms. Coronary MRA does not require radiation exposure and a contrast agent. Coronary MRA might be a useful modality to follow patients treated with fully bioresorbable polymeric scaffolds.

Conflict of interest statement

K. Tanabe is a member of the Advisory Board of Abbott Vascular Japan and receives lecture honoraria from Abbott Vascular Japan. The other authors have no conflicts of interest to declare.

Volume 12 Number 12
Dec 20, 2016
Volume 12 Number 12
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV11I12A259 Mar 18, 2016
Oversized post-dilatation of current bioresorbable vascular scaffolds: kill or cure?
von Birgelen C and Basalus M
free
Trending articles
69.996

10.4244/EIJV13I12A217 Dec 8, 2017
Swimming against the tide: insights from the ORBITA trial
Al-Lamee R and Francis D
free
59.65

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
57.6

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
38.75

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
15.85

State-of-the-Art

10.4244/EIJ-D-23-01050 Jul 15, 2024
Durability of transcatheter aortic valve implantation
Ternacle J et al
free
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
What type of bioresorbable scaffold was used?
How was the patient followed up after scaffold implantation?
What imaging modalities were used and what were the findings?
What were the clinical implications of the imaging findings?
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved